 |
|
|
| Date: | Saturday, 14 June 2003 |
| Time: | 08:30-09:45 |
| Room: | Plenary room (Halle Tony Garnier) |
| 08:30-08:45 |
0406 |
|
|
SAFETY AND EFFECT ON WBC COUNT AND CD34 CELL MOBILIZATION FOLLOWING ADMINISTRATION OF AMD3100 TO PATIENTS WITH MULTIPLE MYELOMA OR NON-HODGKINS LYMPHOMA
S. Devine, N. Flomenberg, D. Vesole, J. Liesveld, D. Weisdorf, K. Badel, G. Calandra, J. DiPersio (St Louis, United States of America)
| 08:45-09:00 |
0407 |
|
|
ELEVATED SERUM FREE LIGHT CHAIN CONCENTRATIONS IN MULTIPLE MYELOMA PATIENTS WITH INTACT IMMUNOGLOBULIN MONOCLONAL PROTEINS; THEIR USE FOR DISEASE MONITORING
G.P. Mead, H.D. Carr-Smith, M.T. Drayson, A.R. Bradwell (Birmingham, United Kingdom)
| 09:00-09:15 |
0408 |
|
|
REDUCED-INTENSITY CONDITIONING WITH LOW DOSE ATG OR ALEMTUZUMAB FOLLOWED BY ALLOGENEIC PBSC: A SALVAGE THERAPY WITH AN ENCOURAGING RESPONSE RATE AND LIMITED TOXICITY IN HIGH RISK MYELOMA PATIENTS
P. Corradini, J. Mariotti, V. Montefusco, F. Ciceri, L. Farina, R. Milani, J. Peccatori, A.M. Gianni, D. Soligo, A. Olivieri, V. Perfetti, M. Bregni (Milan, Italy)
| 09:15-09:30 |
0409 |
|
|
INTERMEDIATE DOSE VERSUS HIGH DOSE MELPHALAN AFTER INITIAL VAMP/VAD THERAPY FOR MYELOMA: A MULTICENTRE RANDOMISED STUDY
H.E. Oakervee, J.D. Cavenagh, A. Eden, E. Rhodes, A. Kruger, S. Smith, S. Rule, A. Brownell, A. Hughes, I. Grant, R. Evely, M. Hamon, C. Kranjniewski, S. Curtis, N.C. McBride, C.R.J. Singer (London, United Kingdom)
| 09:30-09:45 |
0410 |
|
|
PROGNOSTIC FACTORS AT THE TIME OF AUTOTRANSPLANTATION WITH 200 MG/M2 MELPHALAN : A SINGLE-CENTER STUDY OF 451 MYELOMA (MM) PATIENTS
B. Sirohi, B. Sirohi, R. Powles, J. Mehta, S. Kulkarni, C. Horton, R. Saso, S. Singhal (Sutton, United Kingdom)
|